John M. McCall
ReveraGen BioPharma (United States)(US)
Publications by Year
Research Areas
Traumatic Brain Injury and Neurovascular Disturbances, Synthesis and Characterization of Heterocyclic Compounds, Muscle Physiology and Disorders, Neuropeptides and Animal Physiology, Chemical Synthesis and Analysis
Most-Cited Works
- → A call for transparent reporting to optimize the predictive value of preclinical research(2012)1,197 cited
- → [3H]U-69593 a highly selective ligand for the opioid κ receptor(1985)445 cited
- → Effects of the 21-aminosteroid U74006F on experimental head injury in mice(1988)296 cited
- → Liquid-liquid partition coefficients by high-pressure liquid chromatography(1975)217 cited
- → Therapeutic Potential of the Lazaroids (21-Aminosteroids) in Acute Central Nervous System Trauma, Ischemia and Subarachnoid Hemorrhage(1994)215 cited
- → VBP15, a novel anti‐inflammatory and membrane‐stabilizer, improves muscular dystrophy without side effects(2013)188 cited
- →